Standard rotation brings many prices to their lowest. Through some examples of his Nine Months of Portfolio Management series, Sylvain exposes which cards are likely to constitute good investments when fall comes.

Mike Lanigan looks at Standard right before the SCG Invitational and considers the financial impact of Conspiracy and M15.

If Elspeth is so powerful in R/G Monsters in Block, why not jam her in the Standard equivalent? Mike Lanigan makes the case for a Standard port of R/G Elspeth.

While Block Pro Tours are not a perfect predictor of post-rotation Standard, they can still provide valuable insights. Danny Brown looks to Atlanta to see what lessons we can draw this year.

Identifying which players drive demand for a given spec will provide insight into the appropriate buying window. Danny Brown explains, with myriad examples.

The summer lull in Standard is the time to start considering what to do with last block’s cards. Danny Brown examines this year’s batch in detail.

This year price indices of rotating sets are behaving differently than usual. Matthew Lewis offers some possible explanations and considers what it means for the speculator.

Danny advises staying away from Theros cards for the time being, suggesting alternatively a slew of RTR cards he thinks are primed for spikes. He also gives an update on his Zero to Draft endeavor.

Speculation is rampant as we approach Standard rotation, but recent gains may not be sustainable. Sigmund provides a word of caution on letting emotions guide you.

Power level is the principle determinant for a good spec target. Corbin Hosler looks at post-rotation price changes from last year and applies lessons to Return to Ravnica block.

Matthew Lewis revisits the MTGO-to-paper ratio as it stands before rotation, to identify opportunities in the near-term and expand upon the theory behind the metric.

Mike Lanigan examines the Standard and Block Constructed decks that lose the least to rotation, and are likely to form the backbone of the new Standard.

Danny has his eye on Innistrad as rotation approaches, looking for juicy Modern targets.